CNTB · Categories · Form 4
CNTB - SEC Form 4 insider transactions
Connect Biopharma Holdings Limited (CNTB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for CNTB
- Director Xanthopoulos Kleanthis Gabriel was granted 5,000 units of Ordinary Shares, increasing direct ownership by 6% to 91,554 units (SEC Form 4)4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
- Director Liu Jean I was granted 8,984 units of Ordinary Shares, increasing direct ownership by 76% to 20,763 units (SEC Form 4)4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
- Director Xanthopoulos Kleanthis Gabriel was granted 3,738 units of Ordinary Shares, increasing direct ownership by 5% to 86,554 units (SEC Form 4)4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
- Director Liu Jean I was granted 6,718 units of Ordinary Shares, increasing direct ownership by 133% to 11,779 units (SEC Form 4)4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
- SEC Form 4 filed by Xanthopoulos Kleanthis Gabriel4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
- SEC Form 4 filed by Liu Jean I4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
- SEC Form 4 filed by Huang James4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)